Top News
Regeneron Pharmaceuticals acquires 23andMe’s Personal Genome Service, Total Health and Research Services businesses, and Biobank and related assets for $256 million at bankruptcy auction, beating out a bid from co-founder and former CEO…
Continue Reading
What You Should Know:
– Regeneron Pharmaceuticals, Inc. announced it has been named the successful bidder in the bankruptcy auction for substantially all of the assets of 23andMe Holding Co.
– Regeneron plans to acquire 23andMe’s…
Continue Reading
For the 164th episode of the Healthcare IT Today Podcast, we are talking about 23andMe and privacy! We kick this episode off by discussing 23andMe's declaration of bankruptcy to theorize what we think this…
Continue Reading
Top News
California-based consumer genetic testing company 23andMe files for Chapter 11 bankruptcy protection.
Co-founder Anne Wojcicki has stepped down as CEO, but remains on the board and plans to bid independently to buy the…
What You Should Know:
– 23andMe, a human genetics and biotechnology company, has announced its decision to initiate voluntary Chapter 11 proceedings in the U.S. Bankruptcy Court for the Eastern District of Missouri.
– The bankruptcy…
Continue Reading
Human genetics and biotechnology company 23andMe has filed for Chapter 11 proceedings in the U.S. Bankruptcy Court for the Eastern District of Missouri to facilitate a sales process. In a press release, the company said…
Continue Reading
Top News
CVC Capital Partners will likely acquire German health IT company CompuGroup Medical in a take-private deal valued at $1.2 billion. The acquisition is expected to close in the first half of 2025.
CGM…
A Silicon Valley-based startup formerly known as Ciitizen relaunched as Citizen Health on Tuesday — as well as announced a $14.5 million seed funding round led by Transformation Capital and a new partnership with…
Continue Reading
PursueCare, a company that provides personalized virtual addiction treatment, announced the re-release of FDA-cleared RESET and RESET-O, prescription digital therapeutics for substance use disorder and opioid use disorder.RESET and RESET-O were initially developed and…
Continue Reading
What You Should Know:
– The hospital and health system merger and acquisition (M&A) market experienced a significant surge in activity during the third quarter of 2024, reaching its highest level since 2017, according to…
Continue Reading
